Svatek R - Search Results

1

Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.

Lerner SP, Bajorin DF, Dinney CP, Efstathiou JA, Groshen S, Hahn NM, Hansel D, Kwiatkowski D, O'Donnell M, Rosenberg J, Svatek R, Abrams JS, Al-Ahmadie H, Apolo AB, Bellmunt J, Callahan M, Cha EK, Drake C, Jarow J, Kamat A, Kim W, Knowles M, Mann B, Marchionni L, McConkey D, McShane L, Ramirez N, Sharabi A, Sharpe AH, Solit D, Tangen CM, Amiri AT, Van Allen E, West PJ, Witjes JA, Quale DZ. Lerner SP, et al. Among authors: svatek r. Bladder Cancer. 2016 Apr 27;2(2):165-202. doi: 10.3233/BLC-160053. Bladder Cancer. 2016. PMID: 27376138 Free PMC article.

2

Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection.

Svatek RS, Spiess PE, Sundi D, Tu SM, Tannir NM, Brown GA, Kamat AM, Wood CG, Pisters LL. Svatek RS, et al. Cancer. 2009 Mar 15;115(6):1310-7. doi: 10.1002/cncr.24145. Cancer. 2009. PMID: 19156903 Free article.

3

Novel therapeutics for patients with non-muscle-invasive bladder cancer.

Svatek RS, Kamat AM, Dinney CP. Svatek RS, et al. Expert Rev Anticancer Ther. 2009 Jun;9(6):807-13. doi: 10.1586/era.09.32. Expert Rev Anticancer Ther. 2009. PMID: 19496717 Review.

4

Cardiac history and risk of post-cystectomy cardiac complications.

Fisher MB, Svatek RS, Hegarty PK, McGinniss JE, Hightower C, Grossman HB, Kamat AM, Dinney CP, Matin SF. Fisher MB, et al. Urology. 2009 Nov;74(5):1085-9. doi: 10.1016/j.urology.2009.04.103. Epub 2009 Sep 16. Urology. 2009. PMID: 19758689 Free PMC article.

5

Editorial comment.

Kamat AM, Svatek R. Kamat AM, et al. Among authors: svatek r. J Urol. 2009 Dec;182(6):2630; discussion 2631. doi: 10.1016/j.juro.2009.08.184. Epub 2009 Oct 17. J Urol. 2009. PMID: 19836780 No abstract available.

6

Words of wisdom. Re: Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection. Lotan Y, Shariat SF; NMP22 Study Group. BJU Int 2008;101:1362-7.

Svatek RS, Dinney CP. Svatek RS, et al. Eur Urol. 2009 Jul;56(1):217-8. doi: 10.1016/j.eururo.2009.04.014. Eur Urol. 2009. PMID: 19995517 No abstract available.

7

Words of wisdom. Re: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

Svatek RS, Dinney CP. Svatek RS, et al. Eur Urol. 2009 Oct;56(4):745-6. doi: 10.1016/j.eururo.2009.07.013. Eur Urol. 2009. PMID: 19995527 No abstract available.

8

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.

McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, Siefker-Radtke A, Dinney C. McConkey DJ, et al. Among authors: svatek r. Cancer Metastasis Rev. 2009 Dec;28(3-4):335-44. doi: 10.1007/s10555-009-9194-7. Cancer Metastasis Rev. 2009. PMID: 20012924 Free PMC article. Review.

9

Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy.

Svatek RS, Siefker-Radtke A, Dinney CP. Svatek RS, et al. Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S228-31. doi: 10.5489/cuaj.1203. Can Urol Assoc J. 2009. PMID: 20019991 Free PMC article.

10

Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria.

Svatek RS, Fisher MB, Matin SF, Kamat AM, Grossman HB, Nogueras-González GM, Urbauer DL, Kennedy KA, Dinney CP. Svatek RS, et al. J Urol. 2010 Mar;183(3):929-34. doi: 10.1016/j.juro.2009.11.038. Epub 2010 Jan 18. J Urol. 2010. PMID: 20083264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters